跳至主要内容
临床试验/NCT02431390
NCT02431390Unknown不适用

Effect of RAPAELⓇ Smart Glove Digital Treatment System on Upper Limb Functional Recovery and Brain Plasticity in Stroke Patients

Pusan National University2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2015年5月最近更新:
适应症

试验速览

阶段
不适用
入组人数
80
试验地点
2
主要终点
Change in upper extremity function (FMA)

研究概览

简要总结

This study is to investigate whether the RAPAELⓇ Smart Glove digital treatment system improves the upper extremity function of stroke patients compared to other clinical treatment by measuring serial behavioral and neuroimaging assessments and to find out therapeutic effect or adverse effect and patient's feed back responses

详细描述

80 stroke patients(subacute=40, chronic=40) were recruited and randomized to receive either occupation therapy(OT) with or without RAPAELⓇ Smart Glove digital therapy. Groups were divided as follow: Group 1 (5times/4wks, total 20 sessions) Conventional occupation therapy + additional occupation therapy(30min). Group 2 (5times/4wks, total 20 sessions) Conventional occupation therapy + RAPAELⓇ Smart Glove digital treatment(30min).

After the baseline assessment, patients are divided into two groups by drawing for simple random sampling. Total four times of behavioral and neuroimaging assessments were evaluated at baseline, immediately and 2 weeks after each 10 sessions and at 4 weeks after the final session. Assessment tools are as follow:

  1. Primary outcome.

-Fugl-Meyer assessment, 2. Motor and sensory function. MMT&ROM, Motricity index(MI),Action Research Arm test(ARAT), Box&block test, Box&Block test, 9-hole pegboard test, Jebsen-Taylor hand function test, Modified Ashworth scale(MAS), Grip strength test, Grasp/pinch power, Visual analogue scale(VAS), Sensory test(two point discrimination, monofilament) 3. Activity of daily living. Korean version of Modified Barthel index (K-MBI) 4. Cognition function test. Korean-mini mental state examination (K-MMSE) 5. Depressive mood. Korean-Geriatric Depression Scale (K-GDS) 6. Quality of life. Short form-8(SF-8) 7. Neuroimaging tools. Motor evoked potentials (MEP), Functional Magnetic Resonance Imaging (fMRI), Functional near-infrared spectroscopy (fNIRS).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects who hemiplegic due to stroke
  • Subjects who have more than 22 points of Fugl-Meyer Assessment score in upper extremity
  • 40 subjects who have diagnosed as stroke before 3weeks to 3 months(subacute)
  • 40 subjects who have diagnosed as stroke more than 6 months ago(chronic)

排除标准

  • Subjects who have spasticity and upper extremity dysfunction at unaffected side
  • Subjects who have bilateral or multiple brain lesion
  • Subjects who have non-controllable medial or surgical disease
  • Subjects who is less than 20 years old
  • Subjects who have pre-existing and active major neurological or psychiatric disease
  • Subjects who have less than 10 degrees of active wrist range of motion
  • Subjects who can not complete outcome measurement task
  • Subjects who have limitation of communication due to aphasia
  • Subjects who have less than 17 points of K-MMSE
  • Subjects who is pregnant
  • Subjects who have pain or other muscle wasting disease which may interrupt upper extremity exercise

结局指标

主要结局

Change in upper extremity function (FMA)

时间窗: 2 weeks

Fugl-Meyer Assessment(FMA) of upper extremity

次要结局

  • Change in brain plasticity (fNIRS)(baseline and 4 weeks and 8 weeks)
  • Change in upper extremity function (MEP)(baseline and 4 weeks and 8 weeks)
  • Change in upper extremity function(MMT&ROM)(baseline and 2,4,8 weeks)
  • Change in activities of daily livings (MI)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (ARAT)(baseline and 2,4,8 weeks)
  • Change in brain plasticity (fMRI)(baseline and 4 weeks and 8 weeks)
  • Change in upper extremity function (FMA)(baseline and 2,4,8 weeks)
  • Change in depressive mood (K-GDS)(baseline and 2,4,8 weeks)
  • Change in quality of life (SF-8)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (Box&Block test)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (9-hole pegboard test)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (Jebson-Taylor Hand Function Test)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (Modified Ashworth scale)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (Grip strength test)(baseline and 2,4,8 weeks)
  • Change in upper extremity function (Grasp/Pinch power)(baseline and 2,4,8 weeks)
  • Change in upper extremity sensory function (VAS)(from baseline to 2 weeks after each 10 session and 4 weeks after final the session)
  • Change in upper extremity sensory function (Two point discrimination and Monofilament)(baseline and 2,4,8 weeks)
  • Change in activities of daily livings (K-MBI)(baseline and 2,4,8 weeks)
  • Change in cognition function (K-MMSE)(baseline and 2,4,8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yong-il Shin

Associate Professor

Pusan National University

研究点 (2)

Loading locations...

相似试验